Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Disease 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Blood Specimen Collection 5 pembrolizumab 2 fluciclovine F-18 2 Surveys and Questionnaires 2 Preoperative Exercise 2 Magnetic Resonance Imaging 2 Exercise 2 Cryosurgery 2 Bevacizumab 2 tislelizumab 1 neratinib 1 imetelstat 1 daratumumab 1 atezolizumab 1 abiraterone 1 Waiting Lists 1 Videotape Recording 1 Urine Specimen Collection 1 Transcutaneous Electric Nerve Stimulation 1 Tomography, X-Ray Computed 1 Thoracic Surgical Procedures 1 TIC10 compound 1 Sulfonylurea Compounds 1 Standard of Care 1 Specimen Handling 1 Sodium-Glucose Transporter 2 Inhibitors 1 Serologic Tests 1 Sequence Analysis, RNA 1 S-Adenosylmethionine 1 Referral and Consultation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Diagnosis, Computer-Assisted × 1 year × Clear all

NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

105 enrolled 15 charts

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡